Author

B. K. Jha

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

A. Berezovsky· 1 shared A. M. Zidan· 1 shared B. A. Bell· 1 shared B. Hamilton· 1 shared B. Przychodzen· 1 shared B. Tomlinson· 1 shared C. Hong· 1 shared C. Schuerger· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Berezovsky

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivFeb 20, 2020

Resistance to decitabine and 5-azacytidine emerges from adaptive responses of the pyrimidine metabolism network

X. Gu, R. Tohme, B. Tomlinson…·Y. Saunthararajah

This paper identifies adaptive metabolic responses in pyrimidine metabolism as a mechanism of resistance to decitabine and 5-azacytidine, and shows that alternating these drugs with metabolic inhibitors can extend DNMT1 depletion and delay leukemia relapse.

DOI 10.1038/s41375-020-1003-x

humanbulk RNA-seq

Cancer BiologybioRxivMar 26, 2018

Development of a Cx46 targeting strategy for cancer stem cells

E. E. Mulkearns-Hubert, L. A. Torre-Healy, D. J. Silver…·J. D. Lathia

This study identifies clofazimine as a Cx46 inhibitor that targets glioblastoma cancer stem cells by disrupting gap junction communication, enhancing the efficacy of temozolomide.

DOI 10.1016/j.celrep.2019.03.079

humanexperimental assay